APA (7th ed.) Citation

Wygoda, Z., Kula, D., Bierzyńska-Macyszyn, G., Larysz, D., Jarząb, M., Właszczųk, P., . . . Jarząb, B. (2006). Use of Monoclonal Anti-EGFR Antibody in the Radioimmunotherapy of Malignant Gliomas in the Context of EGFR Expression in Grade III and IV Tumors. Hybridoma: A Journal of Molecular Immunology & Experimental & Clinical Immunotherapy, 25(3), 125. https://doi.org/10.1089/hyb.2006.25.125

Chicago Style (17th ed.) Citation

Wygoda, Zbigniew, et al. "Use of Monoclonal Anti-EGFR Antibody in the Radioimmunotherapy of Malignant Gliomas in the Context of EGFR Expression in Grade III and IV Tumors." Hybridoma: A Journal of Molecular Immunology & Experimental & Clinical Immunotherapy 25, no. 3 (2006): 125. https://doi.org/10.1089/hyb.2006.25.125.

MLA (9th ed.) Citation

Wygoda, Zbigniew, et al. "Use of Monoclonal Anti-EGFR Antibody in the Radioimmunotherapy of Malignant Gliomas in the Context of EGFR Expression in Grade III and IV Tumors." Hybridoma: A Journal of Molecular Immunology & Experimental & Clinical Immunotherapy, vol. 25, no. 3, 2006, p. 125, https://doi.org/10.1089/hyb.2006.25.125.